Our Illinois telemedicine weight loss program is designed to deliver real results, utilizing the power of Wegovy and Zepbound under expert medical guidance
The main goal of this approach is to reap the metabolic effects of the medication while minimizing the risk of side effects and prioritizing comfort and adherence
Tolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes: a 12-week, randomized, placebo-controlled, phase 2 study comparing different dose-escalation schemes
Longer term For longer protocols, review metabolic, kidney, liver, and cardiovascular trends every 3-6 months with a clinician
The patient portal is accessible at feelgoodmeds.portal.tellescope.com
Common errors include injecting repeatedly in the same spot, incorrect depth, reusing needles, and not holding the pen in place long enough after injection